Back to "The aHRs (95% CI) of HZO, hospitalized A..."
Strong Support
correlational
History

Adults aged 50 and older who receive the recombinant shingles vaccine have a 42.5% lower risk of being hospitalized for stroke and a 28% lower risk of being hospitalized for a heart attack, possibly...

59
Pro
0
Against

Evidence from Studies

Supporting (1)

59

Community contributions welcome

59

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years

Cohort Study
Human
2025 Dec 24

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years

Score: 59
DOI: 10.1093/cid/ciaf440